PT - JOURNAL ARTICLE AU - Xi Jiang AU - Xiao-Jing Shou AU - Zhongbo Zhao AU - Fanchao Meng AU - Jiao Le AU - Tianjia Song AU - Xinjie Xu AU - Xiaoyan Ke AU - Yuzhong Chen AU - Xiaoe Cai AU - Weihua Zhao AU - Juan Kou AU - Ran Huo AU - Ying Liu AU - Huishu Yuan AU - Yan Xing AU - Jisheng Han AU - Songping Han AU - Yun Li AU - Hua Lai AU - Lan Zhang AU - Meixiang Jia AU - Jing Liu AU - Keith M. Kendrick AU - Rong Zhang TI - A brain structural connectivity biomarker for diagnosis of autism spectrum disorder in early childhood AID - 10.1101/2021.11.03.21265845 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.03.21265845 4099 - http://medrxiv.org/content/early/2021/11/04/2021.11.03.21265845.short 4100 - http://medrxiv.org/content/early/2021/11/04/2021.11.03.21265845.full AB - Objective Autism spectrum disorder (ASD) is associated with altered brain development, but it is unclear which specific structural changes may serve as potential diagnostic markers. This study aimed to identify and model brain-wide differences in structural connectivity using MRI diffusion tensor imaging (DTI) in young ASD and typically developing (TD) children (3·5-6 years old).Methods Ninety-three ASD and 26 TD children were included in a discovery dataset and 12 ASD and 9 TD children from different sites included as independent validation datasets. Brain-wide (294 regions) structural connectivity was measured using DTI (fractional anisotropy, FA) under sedation together with symptom severity and behavioral and cognitive development. A connection matrix was constructed for each child for comparisons between ASD and TD groups. Pattern classification was performed and the resulting model tested on two independent datasets.Results Thirty-three structural connections showed increased FA in ASD compared to TD children and associated with both symptom severity and general cognitive development. The majority (29/33) involved the frontal lobe and comprised five different networks with functional relevance to default mode, motor control, social recognition, language and reward. Overall, classification accuracy is very high in the discovery dataset 96.77%, and 91·67% and 88·89% in the two independent validation datasets.Conclusions Identified structural connectivity differences primarily involving the frontal cortex can very accurately distinguish individual ASD from TD children and may therefore represent a robust early brain biomarker.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Key Technological Projects of Guangdong Province (grant number 2018B030335001 - KMK), Beijing Municipal Science & Technology Commission (grant number Z181100001518005 - RZ), the National Key Research and Development Program of China (2016YFC0105501 - RZ), Sichuan Science and Technology Program (2021YJ0247 - XJ), National Natural Science Foundation of China (61976045 - XJ, 81801779 - SXJ).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:1. For Discovery dataset (Beijing), the ethics committee of the Peking University Institutional Review Board gave ethical approval for this work (approval no. IRB00001052-13079). 2. For ASD validation dataset (Chengdu), the ethics committee of the University of Electronic Science and Technology of China gave ethical approval for this work (approval no. 1420190601). 3. For TD validation dataset (Nanjing), the medical ethics committee of the Brain Hospital affiliated to Nanjing Medical University gave ethical approval for this work (approval no. KY043).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors